119 related articles for article (PubMed ID: 36030750)
1. Integration of OV6 expression and CD68
Wang MD; Xiang H; Zhang L; Wang C
Transl Oncol; 2022 Nov; 25():101509. PubMed ID: 36030750
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients.
Wang MD; Xiang H; Hong TY; Mierxiati A; Yan FH; Zhang L; Wang C
BMC Cancer; 2023 Jun; 23(1):593. PubMed ID: 37370037
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of combining high mobility group Box-1 and OV-6 expression in hepatocellular carcinoma.
Zhu J; Yu H; Chen S; Yang P; Dong Z; Ling Y; Tang H; Bai S; Yang W; Tang L; Shen F; Wang H; Wen W
Sci China Life Sci; 2018 Aug; 61(8):912-923. PubMed ID: 29441453
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.
Ren CX; Leng RX; Fan YG; Pan HF; Li BZ; Wu CH; Wu Q; Wang NN; Xiong QR; Geng XP; Ye DQ
Oncol Rep; 2017 Aug; 38(2):886-898. PubMed ID: 28656201
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein promotes the stem-like properties of OV6
Wang C; Wang MD; Cheng P; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Wu MC; Zhou WP
Cell Death Dis; 2017 Jan; 8(1):e2560. PubMed ID: 28102846
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.
Feng Q; Chang W; Mao Y; He G; Zheng P; Tang W; Wei Y; Ren L; Zhu D; Ji M; Tu Y; Qin X; Xu J
Clin Cancer Res; 2019 Jul; 25(13):3896-3907. PubMed ID: 30988081
[TBL] [Abstract][Full Text] [Related]
8. The correlation between tumor-associated macrophages and the prognosis of east Asian hepatocellular carcinoma patients: A systematic review and meta-analysis.
Qi YQ; Xiong F; Chen YJ
Pathol Res Pract; 2023 Dec; 252():154919. PubMed ID: 37939428
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection.
Shu QH; Ge YS; Ma HX; Gao XQ; Pan JJ; Liu D; Xu GL; Ma JL; Jia WD
J Cell Mol Med; 2016 Jun; 20(6):1024-35. PubMed ID: 26843477
[TBL] [Abstract][Full Text] [Related]
11. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
12. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
[TBL] [Abstract][Full Text] [Related]
13. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
[TBL] [Abstract][Full Text] [Related]
14. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
16. Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients.
Wang C; Hong T; Wang Y; Gan S; Wang Q; Li J; Zuo L; Cui X
Oncoimmunology; 2020; 9(1):1736793. PubMed ID: 32313718
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of CD68+ tumor-associated macrophages in hepatocellular carcinoma: A meta-analysis.
Jin D; Qian L; Chen J; Yu Z; Dong J
Medicine (Baltimore); 2024 Apr; 103(16):e37834. PubMed ID: 38640338
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of tumor-associated macrophage infiltration in supraglottic laryngeal carcinoma.
Lin JY; Li XY; Tadashi N; Dong P
Chin J Cancer; 2011 Apr; 30(4):280-6. PubMed ID: 21439250
[TBL] [Abstract][Full Text] [Related]
20. Macrophage profile in primary versus secondary liver tumors.
Avădănei ER; Wierzbicki PM; Giuşcă SE; Grigoraş A; Amălinei C; Căruntu ID
Folia Histochem Cytobiol; 2014; 52(2):112-23. PubMed ID: 25007179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]